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heterooligomers in a unique 3 to 1 subunit ratio 
Abstract 
Various mammalian small heat-shock proteins (sHSPs) can interact with one another to form large 
polydisperse assemblies. In muscle cells, HSPB2/MKBP (myotonic dystrophy protein kinase-binding 
protein) and HSPB3 have been shown to form an independent complex. To date, the biochemical 
properties of this complex have not been thoroughly characterized. In this study, we show that 
recombinant HSPB2 and HSPB3 can be successfully purified from E.coli cells co-expressing both 
proteins. Nanoelectrospray ionization mass spectrometry and sedimentation velocity analytical 
ultracentrifugation analysis showed that HSPB2/B3 forms a series of well defined hetero-oligomers, 
consisting of 4, 8, 12, 16, 20 and 24 subunits, each maintaining a strict 3:1 HSPB2:HSPB3 subunit ratio. 
These complexes are thermally stable up to 40 °C, as determined by far-UV circular dichroism 
spectroscopy. Surprisingly, HSPB2/B3 exerted a poor chaperone-like and thermoprotective activity, which 
is likely related to the low surface hydrophobicity, as revealed by its interaction with the hydrophobic 
probe 1-anilino-8-naphthalenesulfonic acid. Co-immunoprecipitation experiments demonstrated that the 
HSPB2/B3 oligomer cannot interact with HSP20, HSP27 or αB-crystallin, whereas the homomeric form of 
HSPB2, thus not in complex with HSPB3, could efficiently associate with HSP20. Taken altogether, this 
study brings evidence that despite the high sequence homology within the sHSP family, the biochemical 
properties of the HSPB2/B3 complex are distinctly different from other sHSPs, indicating that the HSPB2/
B3 assembly likely possesses other cellular functions than its family members. 
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HETEROOLIGOMERS IN A UNIQUE 3 TO 1 SUBUNIT RATIO AND EXHIBIT A POOR 
CHAPERONE-LIKE ACTIVITY* 
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Various mammalian small heat shock proteins (sHSPs) can interact with one another to 
form large polydisperse assemblies. In muscle cells, HSPB2/MKBP (myotonic dystrophy protein 
kinase-binding protein) and HSPB3 have been shown to form an independent complex. To date, 
the biochemical properties of this complex have not been thoroughly characterized. In this 
study, we show that recombinant HSPB2 and HSPB3 can be successfully purified from E.coli 
cells co-expressing both proteins. Nanoelectrospray ionization mass spectrometry and 
sedimentation velocity analytical ultracentrifugation analysis showed that HSPB2/B3 forms a 
series of well defined hetero-oligomers, consisting of 4, 8, 12, 16, 20 and 24 subunits, each 
maintains a strict 3:1 HSPB2:HSPB3 subunit ratio. Analyzing the thermal stability of the 
HSPB2/B3 assembly by far-UV circular dichroism spectroscopy revealed subtle structural 
changes, occurring slightly above 40 °C, and an unfolding curve with an inflection point at 
approximately 56 °C. Furthermore, HSPB2/B3 exerted poor chaperone-like and 
thermoprotective activity, which is likely related to the low surface hydrophobicity, as revealed 
by its interaction with the hydrophobic probe 1-anilino-8-naphthalenesulfonic acid. Finally, co-
immunoprecipitation experiments demonstrated that the HSPB2/B3 oligomer does not interact 
with HSP20, HSP27 or αB-crystallin. However, HSPB2 that is not in complex with HSPB3 was 
found to efficiently associate with HSP20. Taken altogether, this study brings evidence that 
despite the high sequence homology of the subunits to other sHSPs, biochemical properties of 
the HSPB2/B3 complex are distinct different from other sHSP assemblies. Our results clearly 





Small heat shock proteins (sHSPs) are 
molecular chaperones characterized by the 
presence of a conserved sequence of about 80-
100 residues, referred to as the α-crystallin 
domain (for recent reviews see (1-3). This 
domain forms the C-terminal part of the protein, 
and is folded into a β-sandwich structure (4-6). 
The N-terminal part is more variable in both 
length and sequence, and largely determines the 
association properties of the homo- or 
heteromeric oligomers of sHSPs (7-9). The α-
crystallin domain generally has a short and 
flexible C-terminal extension which modulates 
the chaperone-like activity, possessed by most 
sHSPs (10-12). sHSPs can form macromolecular 
associations up to 800 kDa, which readily 
dissociate and exchange subunits (13;14). In 
vitro, sHSPs typically display chaperone-like 
activities, measured by their ability to protect 
model substrates from thermally or chemically 
induced aggregation (15;16). In vivo, different 
sHSPs are implicated in an array of cellular 
processes, varying from muscle contraction, cell 
migration and cell survival to redox state and 
apoptosis (see reviews see (17-19)). 
In human, ten members of the sHSP 
family have been recognized, formally 
designated as HSPB1-HSPB10 (20;21). While 
several sHSPs have extensively been studied, 
only limited information is available for HSPB2 
(MKBP) and HSPB3 (22). HSPB2 and HSPB3 
are mainly expressed in heart and skeletal 
muscle (23;24). In muscle extract HSPB2 and 
HSPB3 has been identified as a hetero-oligomer 
with an apparent molecular mass of 150 kDa. 
This sHSP complex has a more defined size than 
those formed by HSP27, αB-crystallin or 
HSP20, which can vary between 40 and 500 kDa 
(23). HSPB2 was initially discovered as a 
specific binding partner for myotonic dystrophy 
protein kinase (DMPK), hence its alternative 
name MKBP (DMPK-binding protein) (25). 
This interaction results in an enhanced kinase 
activity of DMPK and protects it from heat-
induced inactivation (25). Association of HSPB2 
with the outer membrane of mitochondria 
suggests a role in mitochondrial function 
(26;27). This might be related to the observed 
role of HSPB2 in the protection of the energy 
reserve; mice lacking HSPB2 have a higher rate 
of ATP loss during ischemic stress, and after 
ischemia the recovery of the energy level was 
slower (28). HSPB2 has been also implicated in 
the pathogenesis of diseases. In myotonic 
dystrophy diseased muscles, with reduced 
DMPK levels, an increased expression of 
HSPB2 is observed (25). Furthermore, HSPB2 
can associate with the Aβ-containing plaques in 
Alzheimer’s disease brains possibly preventing 
the pathogenic action of Aβ (29;30).  
Less is known about HSPB3. Based on 
sequence prediction, HSPB3 was found to be the 
smallest member of the family with a 17 kDa 
monomeric size (31). A remarkable feature of 
HSPB3 is the lack of the C-terminal extension 
(31).  In heart extracts, it exclusively interacts 
with HSPB2 (23), and upon proteasomal 
inhibition, ectopically overexpressed HSPB3 can 
translocate to the cytoskeleton in cultured rat 
cardiac H9C2 cells (32). Like HSPB2, the 
expression levels of HSPB3 are not upregulated 
upon heat shock (23). 
Our goals in this study were two-fold: 
(1) to establish the stoichiometry of the 
oligomeric assembly of HSPB2/B3 and (2) to 
characterize the biochemical properties of the 
complex. We show that HSPB2 and HSPB3 
form a series of complexes that are actually 
assemblies of tetrameric HSPB2/B3 complexes 
with a subunit ratio of 3:1. These oligomers were 
found to have poor chaperone and 
thermoprotective activity and are unable to 
interact with other sHSPs, such as HSP20, 





Cloning, expression and purification 
The cDNAs encoding for rat HSPB2 and 
rat HSPB3 were cloned into the pET3a 
expression vector by using the NdeI-BamHI 
sites and BglII-EcoRI sites, respectively. Protein 
expression was induced in the BL21 Rosetta 
strain, transformed with pET3a-HSPB2/B3, by 
addition of 350 µM isopropyl-β-D-
thiogalactopyranoside and subsequent incubation 
for three hours at 37 °C. Cells were lysed by 
sonication in TEG buffer (25 mM Tris, pH 8.0, 2 
mM ethylenediaminetetraacetic acid (EDTA), 50 
mM glucose) and then centrifuged at 16,000 × g 
for 45 min at 4°C. The obtained supernatants 
were subjected to 0.12% polyethylene-imine 
precipitation. SHSPs were first fractionated on a 
DEAE–Sepharose column, using a gradient from 
0 to 1 M NaCl in 25 mM bis-Tris pH 6.35, 2 
mM EDTA, and after desalting further 
fractionated on a Source 15Q HR 16/10 column 
using the same salt gradient. This yielded 
fractions containing both HSPB2 and HSPB3, 
and HSPB2 alone. Recombinant HSP27, HSP20 
and αB-crystallin were purified in a similar 
manner, using pET3a-human-HSP27, pET8c-rat-
HSP20 and pET3b-human-αB-crystallin as 
described previously (33). 
SEC-MALLS 
 SEC-MALLS analyses were performed 
by chromatographic separation of samples (100 
µg), on an Agilent 1200 system, using a TSK-
Gel3000SW column (TOSOH-BIOSEP) at a 
flow rate of 0.5 mL/min in 10 mM sodium 
citrate, pH 6.25, 100 mM NaCl. MALLS 
analysis of a sample was performed 
continuously on the column eluate, as it passed 
through a triple-angle miniDAWN™ TREOS 
light scattering detector in series with an Optilab 
rEX refractive index instrument (both from 
Wyatt Technologies, Inc). Data were analyzed 
using Astra v5.3.2, a dn/dc value of 0.185, an A2 
value of 0, and a 1st order Zimm fit. 
Far-UV circular dichroism spectroscopy 
CD-spectra were recorded on a J-810 
spectropolarimeter (Jasco) in a 1 mm cuvette 
using 250 µg/mL of HSPB2/B3 dialyzed against 
10 mM potassium phosphate buffer pH 7.8. 
Spectra of HSPB2/B3 and buffer alone were 
recorded between 195 and 250 nm with a 
scanning speed of 20 nm/min with a response 
time of 1 second and a bandwidth set to 1 nm. 
To determine the heat stability, the temperature 
of the cuvette was increased from 20 °C up to 80 
°C with 1 °C /min. After each increment of 2 °C 
15 spectra were recorded and averaged. The 
spectra of HSPB2/B3 were corrected for the 
spectra of the buffer at the corresponding 
temperatures. 
Mass spectrometry 
HSPB2/B3 was buffer exchanged from 
the initial buffer into200 mM ammonium 
acetate, pH 6.8, using a Superdex 200 column on 
an AKTA prime FPLC and subsequently 
separated into two fractions, A and B, on a 
Superose 6 column.  From these fractions 
nanoelectrospray mass spectra were acquired 
using a Qstar XL mass spectrometer (MDS 
Sciex), under conditions optimized for the 
transmission of non-covalent protein complex 
interactions, using a previously described 
protocol (34). Typical instrument parameters in 
positive ion mode, were: ion spray voltage 1.2 
kV, declustering potential 100 - 150 V, focusing 
potential 100 V, declustering potential 2 15V, 
quadrupole voltage (Q0) 50 V, collision gas 
(CAD) 6, ion release delay 6 and ion release 
width 5.  Experiments were acquired at 
instrument base pressure of 6.5 mbar.  
Analytical ultracentrifugation 
Samples were placed in assembled cells 
with sapphire windows and 12-mm path length 
centerpieces, which were made of charcoal-filled 
epon, and were centrifuged at 42,000 rpm in an 
eight-holed An50-Ti rotor. The data were 
collected using the absorption detection system 
of the XL-I analytical ultracentrifuge (Beckman 
Coulter) at 276 nm. The cells were aligned 
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manually, the inner cell housing scribe line on 
the bottom of the cell was visually aligned with 
the inner rotor hole scribe lines. Once the 
vacuum was less than 5 µm, the rotor was 
allowed to reach the set temperature of 22 °C 
and then was equilibrated for 1 hour before 
accelerating the rotor to the maximum speed of 
42,000 rpm. The cells were scanned at 276 nm 
as frequently as possible, using a radial 
increment of 0.003 cm. At the end of the 
experiment, the data were analyzed by Sedfit 
(35). 
The c(s) continuous distribution model 
was used with input parameters that include 
radial position for the cell bottom and initial 
position for the meniscus, an initial estimate of 
frictional coefficient ratio (f/f0) of 1.2, the radial 
data range and sedimentation coefficient range 
(0.5-20 S, the resolution was set at 200) for 
fitting. The solvent density and viscosity as well 
as the partial specific volume were calculated 
using the public domain software program 
Sednterp (36). The calculated partial specific 
volume of the HSPB2/B3 oligomer was 
corrected for the subunit ratio of 3:1. An initial 
c(s) distribution was generated using these 
parameters. Subsequently, it was optimized 
using the meniscus position and f/f0 as floating 
parameters. Using the integration tool provided 
in Sedfit, the relative concentration and weight 
average sedimentation coefficients were 
determined for each species. In all cases 
regularization with Tikhonov-Phillips obtained 
the best results. The root mean square deviation 
(rmsd) for all analysis was < 0.004. 
ANS binding 
To study the binding of the hydrophobic 
probe 1-anilino-8-naphthalenesulfonic acid 
(ANS), 10 µM HSPB2/B3 in 10 mM sodium 
phosphate buffer (pH 7.4) containing 100 mM 
NaCl and 500 mM ANS in methanolic solution 
was used to make a series of mixtures with 
different molar ratio’s. The mixtures were 
incubated for 10 min at 37 °C after which the 
fluorescence emission was measured at 490 nm 
using an excitation wavelength of 390 nm.  
Chaperone assays 
To measure the chaperone-like 
properties of sHSPs the insulin protection assay 
described by Farahbakhsh et al. (37) and the 
citrate synthase (CS) assay described by Kappé 
et al. (38) were used. Briefly, for the insulin 
protection assay the proteins were dialyzed 
overnight at 4 °C against buffer containing 20 
mM sodium phosphate, pH 6.9, and 20 mM 
Na2SO4. In a final volume of 1 mL, 250 µg 
HSPB2/B3 or αB-crystallin was incubated with 
250 µg bovine insulin (Sigma) at 40 °C for 5 
minutes. The denaturation of insulin was 
initiated by adding 3 mg dithiothreitol (DTT), 
and absorbance was measured at 360 nm for 15 
minutes at 40 °C in a Perkin Elmer Lambda 2 
UV/VIS spectrophotometer. For the CS 
protection assay the proteins were dialyzed 
overnight at 4 °C against 40 mM Hepes-KOH, 
pH 7.5. 70 µg sHSP was incubated at 44 °C for 5 
minutes. After adding 70 mg CS to a total 
volume of 1 mL the heat induced denaturation of 
the substrate was followed at 44 °C by 
measuring the turbidity at 360 nm for 45 minutes 
in a Perkin Elmer Lambda 2 UV/VIS 
spectrophotometer. 
Colony Survival Assay 
Cells transformed with the appropriate 
bacterial expression construct were first grown 
overnight. All cell suspensions were then diluted 
to OD580 = 0.6, and protein expression was 
induced for 1 hour by adding 350 µM isopropyl-
β-D-thiogalactopyranoside. After induction cells 
were heat-shocked at 48 °C for 60 minutes, after 
which the cell cultures were diluted to OD580 = 
0.06. The recovery was monitored during 4.5 
hour at 37 °C by measuring the increase of 
OD580 at 30 minute time intervals. 
Co-immunoprecipitation assay 
Purified HSPB2/B3 (1 µg) and HSPB2 
(0.5 µg) were incubated either alone (negative 
control) or together with HSP20, HSP27, αB-
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crystallin (5 µg) or a mixture of the three 
proteins (each 5 µg) in TEN buffer (25 mM Tris 
pH 8.0, 100 mM NaCl, 2 mM EDTA and 0.05% 
NP40) for 60 minutes at room temperature. After 
the incubation, antibodies directed against 
HSPB2, HSP20, αB-crystallin (all three raised in 
rabbits) or HSP27 (Stressgen) coupled to protein 
A beads (Roche) were added to the indicated 
mixtures and rotated for 60 minutes. The beads 
were then pelleted and washed 3 times with 1 
mL TEN buffer. The proteins bound to the beads 
were separated by SDS-PAGE and analyzed by 
Western blotting.  
 
RESULTS 
HSPB2 together with HSPB3 forms 
heterooligomeric complexes 
Initially, it was attempted to express and 
purify HSPB2 and HSPB3 separately in order to 
study their properties and to characterize the 
HSPB2/B3 complex. Although separate 
expression of both proteins was adequate, 
purification and stability turned out to be 
unsatisfactory under a variety of conditions. Co-
expression of HSPB2 with HSPB3 already 
allowed the formation of the complex in E. coli, 
and from the extract of those cells HSPB2/B3 
could successfully be purified by ion exchange 
chromatography. In the initial DEAE step, 
HSPB2 eluted at low salt concentrations together 
with HSPB3 in a certain ratio. At higher salt 
concentrations, HSPB2 eluted mainly without 
HSPB3 (Fig. 1A), indicating that E. coli 
expressed an excess of HSPB2 compared to 
HSPB3. Unfortunately, HSPB2 was only stable 
in a diluted form and started to precipitate as 
soon as the concentration was increased. Due to 
this behavior the biochemical properties of 
HSPB2 on its own could not be analyzed. 
Fractions containing both HSPB2 and HSPB3 
were pooled and further purified on a Source Q 
column. The obtained HSPB2 and HSPB3 were 
concentrated in 20 mM phosphate buffer pH 7.5 
with 100 mM NaCl and 2 mM EDTA to a 
concentration of 15 mg/mL (0.77 mM). This 
solution was subsequently diluted into 1 mg/mL 
final concentration and analyzed by size 
exclusion chromatography coupled with multi-
angle laser light scattering (SEC-MALLS). In 
the obtained chromatogram HSPB2/B3 appeared 
in three peaks; a major peak A and a smaller 
peak B, which is poorly separated from a third 
peak C (Fig. 1B). Based on the MALLS 
measurements, the molecular masses of the 
HSPB2/B3 complexes in peaks A and B are 78 
and 166 kDa, respectively. Peak C contains 
several high molecular weight complexes with 
masses ranging from 250 to 300 kDa.  
 
HSPB2/B3 forms hetero-oligomeric complexes 
with a fixed subunit ratio 
To further characterize the HSPB2/B3 
oligomers, the complexes were analyzed by 
nano-ESI-MS under conditions that preserve 
non-covalent interactions (39). The 
unprecedented accuracy of this technique can be 
used to calculate the exact subunit stoichiometry 
of the hetero-oligomers. Prior to mass 
spectrometry, the proteins were separated on a 
Superose 6 column, using a 200 mM ammonium 
acetate buffer at pH 6.8, which gave a similar 
elution pattern with two relatively sharp peaks A 
and B, and a broader peak C (Fig. 2A). This 
broadness is likely caused by the mass variations 
of the large complexes shown by the MALLS 
measurements (Fig. 1B). Mass spectra were 
collected for oligomeric HSPB2/B3 present in 
peak A and peak B containing a fraction of peak 
C. Analysis of peak A (Fig. 2B) revealed an 
intense series of peaks (T) between m/z 3,500-
5,250, which were found to arise from an 
HSPB2/B3 complex with a mass of 77,887 ± 34 
Da. According to the mass this is a tetrameric 
complex (T, 4-mer) composed of three HSPB2 
subunits (calculated mass 20,235 Da) and one 
HSPB3 subunit (calculated mass 16,968 Da). A 
low intensity charge state series between m/z 
1,500-3,200 could be observed (insert to panel 
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B), which arise from three different species: 
HSPB3 monomer with a mass of 17,024 ±1 Da, 
a heterodimer (heteroD) with a mass of 37,294 ± 
9 Da (calculated mass 37,203 Da), and a HSPB2 
homodimer (homoD) with a mass of 40,458 ±39 
Da (calculated mass 40,470 Da). The 
predominant charge state series found in peak B 
(Fig. 2C) corresponds with the mass of an 
octamer (O, 8-mer) being 155,696 ±53 Da 
composed of six HSPB2 and two HSPB3 
subunits. The next most intense peak series in 
this spectrum (mass 467,588 ±127 Da) 
corresponds to a 24-mer and has the same 3:1 
subunit ratio observed in case of the tetra- and 
octa-meric complexes. A low intensity charge 
state series between m/z 5800-8000 (insert to 
panel C) was found to arise from a dodecamer 
oligomer (DoD, 12-mer) with a mass of 233,767 
± 94 and another low intensity series arises from 
a hexadecamer (hexD, 16 mer) with a mass of 
311,853 ±19 Da. Both the dodecamer and 
hexadecamer conform to the same subunit ratio 
observed for the tetramer, octamer and 24-mer.  
In order to determine the relative 
amount of each oligomeric complex, a 
sedimentation velocity centrifugation analysis, 
using an analytical ultracentrifuge (Experimental 
Procedures) was performed. By employing the 
c(s) continuous distribution model, 7 different 
complexes varying in sedimentation rate 
between 4.6 and 19.4 S were identified (Fig. 3). 
Based on the calculated molecular masses of 
these complexes (Table 1), 5 of these complexes 
have been identified by nano-ESI-MS as being 
4-, 8-, 12-, 16- and 24-mer. Also a complex with 
the mass of a 20-mer could be detected, which 
was not observed by nano-ESI-MS, likely 
because of its low abundance. Beside these 
complexes, also a large complex with a mass of 
638,000 Da was detected by analytical 
ultracentrifugation, but the accuracy of this mass 
was not sufficient to determine if this complex 
belongs to the series of well-defined oligomers. 
By analyzing the peak areas we determined the 
relative amount of each oligomer (Table 1). The 
heterotetramer (4-mer) forms more than 60% of 
the amount of all species, indicating that this 
oligomer is the predominant form.  
 
Heat-induced structural changes of HSPB2/B3  
The chaperone-like activity of sHSPs is 
likely modulated by structural changes in 
response to stress, such as elevated temperatures 
(40). To assess heat-induced structural changes 
of HSPB2/B3 a series of far-UV circular 
dichroism (CD) spectra were recorded at 
temperatures ranging from 20 till 80 degrees. 
The CD spectra for HSPB2/B3 recorded 
between 20 and 40 °C were quite similar and 
showed a relatively broad minimum around 215 
nm (Fig. 4A). Above 40 °C, a change in the 
spectra was observed, and found to be most 
pronounced at 204 nm. At this wavelength the 
negative ellipticity is characteristic for random 
coil structures caused by the unfolding of the 
subunits (41). This negative ellipticity at 204 nm 
slightly increased at temperatures ranging from 
40 to 50 °C and strongly increased between 50 
and 64 degrees, with an inflection point of the 
unfolding curve at 56 degrees (Fig. 4B).  
 
Surface hydrophobicity of HSPB2/B3  
The surface hydrophobicity of 
HSPB2/B3 was compared with that of αB-
crystallin. αB-crystallin has a strong affinity for 
unfolding proteins, which correlates well to the 
surface hydrophobicity of this sHSP (42). The 
surface hydrophobicity was measured with the 
hydrophobic probe ANS, a fluorescence dye 
with increasing fluorescence intensity upon 
binding to exposed hydrophobic surfaces. The 
fluorescence intensity was measured at different 
ANS to protein molar ratios (Fig. 5). 
Remarkably, for HSPB2/B3 very little 
fluorescent ANS signal was recorded, even at 
high molar ratios, showing that, compared to 
αB-crystallin, HSPB2/B3 exhibits very low 
ANS binding capacity. This indicates that the 
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surface of HSPB2/B3 is relatively non-
hydrophobic.  
 
HSPB2/B3 has poor chaperone-like and 
thermoprotective activity 
A low surface hydrophobicity is an 
indication for a poor chaperone-like activity. To 
study the chaperone-like activity of HSPB2/B3 
three different chaperone assays were used (Fig. 
6). In the first assay the ability to prevent 
aggregation of dithiothreitol-denatured insulin 
was measured. In line with previous data (37), 
recombinant αB-crystallin fully inhibited the 
DTT-induced aggregation of insulin at a 1-to-1 
mass ratio (Fig. 6A). Conversely, practically no 
prevention of insulin aggregation was observed 
in the presence of HSPB2/B3. In the second 
assay the ability to prevent the heat-induced 
aggregation of citrate synthase (CS) was 
assessed (38). At a 1-to-1 mass ratio both 
HSPB2/B3 and αB-crystallin were able to 
prevent CS aggregation, although HSPB2/B3 
showed significantly less chaperone-like activity 
than αB-crystallin (Fig. 6B). In the third assay, 
the ability of HSPB2/B3 to confer 
thermotolerance to E. coli cells was established 
(Fig. 6C). E. coli cells expressing HSPB2/B3, 
αB-crystallin or the chaperone-like activity 
lacking negative control βB2-crystallin (43), 
were heat shocked for 60 minutes at 48 °C, a 
temperature at which marginal unfolding of 
HSPB2/B3 was detected (Fig. 4B). After heat 
shock, cells were diluted in fresh medium and 
cell recovery at 37 °C was monitored for 4.5 
hours, by measuring the cell density (OD580) at 
30 minutes intervals. After 4.5 hours, a 
considerable growth recovery of αB-crystallin 
expressing cells was observed, while cells 
expressing HSPB2/B3 or the control protein 
were still not recovered. These results show that 
HSPB2/B3 has no (Figs 6A and C) or only little 
(Fig. 6B) chaperone-like and thermoprotective 
activity as compared to αB-crystallin. 
 
Interaction of HSPB2/B3 with other sHSPs 
Although the HSPB2/B3 association in 
muscle cell extracts has been suggested to act 
mainly as an independent sHSP complex since it 
does not associate with HSP27 and αB-
crystallin, a weak interaction between HSP20 
and HSPB2 has been detected (23). To analyze 
whether the recombinant HSPB2/B3 oligomeric 
complexes exhibit similar associating properties, 
a mixture containing equal amounts of purified 
HSP20, HSP27 and αB-crystallin was allowed to 
exchange subunits with HSPB2/B3. In this 
experiment purified HSPB2 was used, which in 
the diluted form remained soluble during co-
immunoprecipitation. After 60 min of incubation 
at room temperature HSPB2 was 
immunoprecipitated with HSPB2 antiserum 
followed by Western blot analysis to detect the 
interacting proteins (Fig. 7A). As expected, 
HSPB3 was efficiently co-precipitated with 
HSPB2 (Fig. 7A lanes 4 and 6). Interestingly, 
HSP20 did not co-precipitate with HSPB2/B3, 
but was efficiently pulled down with HSPB2, 
while αB-crystallin and HSP27 co-precipitated 
neither with HSPB2/B3 nor HSPB2 (compare 
lanes 5 and 6).  
In the reciprocal pull-down experiment 
specific antibodies directed to HSP20, HSP27 
and αB-crystallin were used for the 
immoprecipitation and co-precipitated HSPB2 
was detected by Western blot analysis (Fig. 7B). 
The three sHSPs were incubated with 
HSPB2/B3 or HSPB2 either individually (Fig. 
7B lanes 3-4) or as a mixture (Fig. 7B lanes 5-6). 
Again, only HSP20 showed a clear interaction 
with HSPB2, but not with HSPB2/B3. No 
quantitative differences of co-precipitated 
HSPB2 were observed in the presence of HSP27 
and αB-crystallin, indicating that the interaction 
between HSP20 and HSPB2 is not affected by 
these two sHSPs. These results show that the 
HSPB2/B3 complex does not interact with 
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HSP20, HSP27 or αB-crystallin, while HSPB2 
can indeed form a complex with HSP20.  
 
DISCUSSION 
We succeeded to co-express HSPB2 and 
HSPB3 as reported in this study, and purified the 
oligomeric complex of HSPB2/B3. Interestingly, 
HSPB3 was only detected as a component of this 
complex, while HSPB2 could also be isolated as 
a separate homomeric assembly, albeit in a 
poorly soluble form. Analysis of the 
recombinant HSPB2/B3 complex by advanced 
methods such as SEC-MALLS, Nano-ESI-MS 
and sedimentation velocity centrifugation 
revealed the presence of a series of heteromeric 
oligomers. The masses of these oligomers varied 
from 77,897 up to 467,588 Da, corresponding to 
assemblies containing 1 to 6 tetramers, each 
comprising three HSPB2 and one HSPB3 
subunits (Table 1). The tetramer is the most 
abundant oligomeric species that can be formed 
by HSPB2 and HSPB3. Based on the mass 
differences between the higher oligomers, this 
structure is the building block for the large 
HSPB2/B3 complexes. The 24-mer is likely a 
more stable structure compared to the other 
higher oligomers, since this complex is relatively 
more pronounced as determined by both nano-
ESI-MS (Fig. 2C) and sedimentation analysis 
(compare ratio amount n+4- and n-mer in Table 
1). The organization of HSPB2/B3 in distinct 
oligomeric structures is a very conspicuous 
feature, which to our knowledge, is a feature that 
has never been observed for other sHSPs. 
By Nano-ESI-MS, small amounts of 
HSPB2 homodimers and HSPB2/B3 
heterodimers have been detected (Fig. 2A). This 
observation allowed to draw the conclusion that 
the tetramer is composed of dimeric units. Such 
dimeric “building blocks” have been suggested 
as being a common feature of sHSPs (1;44). In 
this case, the tetramer is formed by the 
association of one homodimer and one 
heterodimer. This fits with the yeast two hybrid 
data showing that HSPB2 interacts with both 
itself and HSPB3, while HSPB3 can only 
interact with HSPB2 and not itself (23).  
Based on the SEC analysis in this study, 
in agreement with earlier reports (23;25;45), the 
main HSPB2/B3 complex was estimated to be in 
the range of an octamer, 150 kDa (Fig. 2A, peak 
A). However, this is twice as large as found by 
mass spectrometry, MALLS and sedimentation 
velocity centrifugation analysis (Fig. 1 and 2B). 
This indicates that HSPB2/B3 elutes faster from 
a size exclusion column than expected. A 
possible explanation for this aberrant behavior 
could be the presence of extra space inside the 
complex, as has been observed for HSP26 (46).  
By heat-induced denaturation we found 
that HSPB2/B3 forms a relatively stable 
structure, which only at temperature around 56 
°C forms extensive random coil structures. 
However, the unfolding starts already at 40 °C, 
which suggests that at this temperature structural 
changes already occur. Such structural changes, 
close to physiological temperatures have been 
also described for other sHSPs, and thus might 
be an important mechanism to regulate the 
chaperone-like activity (40).    
Previously, it was shown that the α-
crystallin domain is needed to form the dimer 
structures, while the N-terminal and C-terminal 
tails are mainly involved in stabilizing the 
quaternary structure (44). The C-terminal 
extensions can form critical bridges between 
neighboring subunits via a conserved IXI/V 
sequence (12). The C-terminal extension of 
HSPB2 does not contain this conserved 
sequence but, based on its length, it could still be 
involved in stabilizing the quaternary structure. 
However, HSPB3 has an extension of about 5 
residues long, which is likely too short to form a 
bridge between adjacent α-crystallin domain 
dimers. The absence of a long C-terminal 
extension in HSPB3 might be an important 
factor for the unique nature of the HSPB2/B3 
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complex to form tetramers that can subsequently 
assemble into multiple oligomers.  
sHSPs expressed in the same cell often 
form heteromeric complexes consisting of 
several sHSPs, such as those described for αB-
crystallin and HSP27 (47). There are also 
examples in which more than one type of sHSP 
oligomeric complexes can actually exist in the 
cytoplasm of a single cell. In higher plants, class 
I and II sHSPs are such proteins that can be 
found in separate oligomers (48). HSPB2 and 
HSPB3 also form separate oligomers, despite 
their co-expression with e.g. HSP27, HSP20 and 
αB-crystallin in muscle cells. Interestingly, 
HSP20 is able to interact with HSPB2 (23), 
which raised the question whether HSP20 can 
also interact with HSPB2 as part of the 
HSPB2/B3 complex. By co-
immunoprecipitation experiments we have 
shown that the HSPB2/B3 complex does not 
interact with HSP20 (Fig. 7). Only HSPB2 
alone, thus not in complex with HSPB3, binds 
relatively well to HSP20. These data show that 
HSPB2/B3 is indeed a separate complex not able 
to interact with other sHSPs. This is in good 
agreement with the yeast two-hybrid studies 
showing that only HSP20 and HSPB3 are able to 
interact with HSPB2 (23). Recently, HSPB2 has 
been found to also interact with HSPB8 (HSP22) 
(49). The concentration of HSPB2 and HSPB3 
in rat skeletal muscle extract was found to be 
0.30 and 0.09 µg/mg of total protein, 
respectively (23). Thus the ratio of expression 
between the two proteins is close to 3:1, which 
suggest that almost all HSPB2 will be present in 
the HSPB2/B3 complex. This may explain why 
in muscle tissue extract only a minor fraction of 
HSPB2 associates with HSP20 (23).  
HSPB2/B3 hardly binds ANS (Fig. 5), 
indicating that the surface of the complex is not 
very hydrophobic. The low surface 
hydrophobicity is likely to affect the binding of 
unfolding proteins (50), and this way, it can 
contribute to the observed poor chaperone-like 
activity of the HSPB2/B3 complex. 
Interestingly, purified homomeric HSPB2 has 
been shown to have chaperone-like activity that 
protects the kinase DMPK from heat-induced 
inactivation (25). By using a diluted preparation 
of purified HSPB2, we could also detect a 
moderate chaperone-like activity of HSPB2 for 
insulin (data not shown). It is thus possible that 
HSPB3, at least in part, is responsible for the 
low chaperone-like activity of the HSPB2/B3 
complex. Therefore, HSPB2/B3 may function as 
an inactive storage complex from which HSPB2 
has to dissociate in order to become active. 
However, the relation between in vitro and in 
vivo chaperone-like activity does not always 
correlate (51) and thus care must be taken to 
extrapolate the in vitro data. It remains possible 
that HSPB2/B3 function as a chaperone complex 
in vivo only dedicated to specific substrates.  
In summary, the results indicate that 
HSPB2/B3 forms a series of heterooligomers 
with a well-defined subunit ratio and differ in 
number of tetramers. They have poor 
chaperoning activity and do not interact with 
other sHSPs, which is atypical compared to 
other sHSPs. Further studies are needed to 
understand the structural and cellular functions 
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FIGURE LEGENDS 
Figure 1. Separation of HSPB2/B3. (A) A lysate of E. coli cells co-expressing HSPB2 and HSPB3 
was separated on a DEAE column with a NaCl gradient. Peak samples were collected and subjected to 
SDS-PAGE and stained with Coomassie Brilliant Blue (CBB). (B) Elution pattern of purified 
HSPB2/B3 on a TSK-Gel3000SW column was measured by absorption at 280 nm (left axis) in 
combination with continuous MALLS measurements converted to molecular masses in Da (right 
axis). HSPB2/B3 eluted as relatively sharp peaks A and B at a mass of 78 kDa and 166 kDa, and a 
front peak C, containing multiple complexes with increasing masses.  
 
Figure 2.  Nanoelectrospray mass spectra of HSPB2/B3. (A) HSPB2/B3 separated by Superose 6 
column in 200 mM ammonium acetate pH 6.8. Fractions of peak A and B were collected. Panel (B) 
shows the higher oligomeric species observed by mass spectrometry acquired with a sample of peak 
A. The dominant charge state series correspond to a HSPB2/B3 tetramer (T) of mass 77897 ± 34 Da 
composed of three 20.2 kDa subunits and a single 17.0 kDa subunit. As an insert of panel B, an 
expansion of the 1500 – 3500 m/z region is shown. Here, three additional species can be identified: a 
monomer (M) with mass 17024 ± 1 Da; a heterodimer (heteroD), with mass 37294 ± 9 Da, composed 
of a single copy of each subunit and a homodimer (homoD), with mass 40458 ± 39 Da, composed of 
two 20.2 kDa subunits. Panel (C) shows the higher oligomeric species observed by mass 
spectrometry, acquired with sample of peak B. The mass of the predominant charge state series in this 
spectrum corresponds to an octamer (O) composed of six 20.2 kDa subunits and two 17.0 kDa in the 
same subunit ratio observed for the tetrameric species in panel B. The next most intense peak series 
corresponds to that of a 24 mer with the same 3:1 subunit ratio observed previously. The insert in 
panel C expands the 5700 – 8000 m/z region of the spectrum. A well defined but low intensity series 
for a dodecameric oligomer (DoD) with mass 233767 ± 94 Da was detected as well as a low intensity 
series for a hexadecamer (hexD) with mass 311853 ± 19 Da. Both the dodecamer and hexadecamer 
conform to the same subunit ratio observed for the tetramer, octamer and 24 mer.  
 
Figure 3. Sedimentation velocity analysis of HSPB2/B3. Purified HSPB2/B3 at 1.5 mg/mL in 20 mM 
phosphate buffer pH 7.5 containing 100 mM NaCl and 2 mM EDTA was centrifuged at 42,000 rpm in 
an analytical ultracentrifuge at 22 °C. A multi-species analysis of the obtained data was used to 
calculate the C(s) distribution of S(w). 
 
Figure 4. Far-UV circular dichroism spectra of HSPB2/B3.  
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(A) Far-UV circular dichroism spectra (B) negative ellipticity at 204 nm of HSPB2/B3 taken after 
every increment of  2 °C  from 20 °C  till 80 °C . Dark lines in (A) indicate spectra and dark squares 
in (B) indicate negative ellipticity at 204 nm taken after increments of 10 °C. Protein concentration 
was 250 µg/mL in 10 mM potassium phosphate buffer pH 7.8. 
 
Figure 5. HSPB2/B3 exhibits has a low affinity for the hydrophobic probe ANS.  
The ANS binding capacity of HSPB2/B3 ( ) and of αB-crystallin (●) was determined by titrating 10 
µM protein with increasing ANS concentrations (plotted as molar ratio ANS/protein) and measuring 
intensities of the fluorescence emission maxima at the excitation wavelength set at 390 nm.  
 
Figure 6. HSPB2/B3 exhibits moderate chaperone-like and thermoprotective activity. (A) Chaperone 
activity of 250 µg HSPB2/B3 ( ) or αB-crystallin (●) determined by measuring the ability to prevent 
DDT-induced aggregation of 250 µg insulin at 40 °C. Insulin alone is indicated by diamonds  ( ). (B) 
Chaperone activity of 70 µg HSPB2/B3 ( ) or αB-crystallin (●) determined by measuring the ability 
to prevent temperature-induced aggregation of 70 µg CS at 44 °C. CS alone is indicated by diamonds 
( ). (C) Thermoprotective activity of HSPB2/B3 or αB-crystallin determined by measuring the 
growth of E. coli cells expressing HSPB2/B3 ( ), αB-crystallin (●) or negative control protein βB2 
( ) after a heat shock at 48 °C for 60 minutes. 
 
Figure 7. HSPB2 but not HSPB2/B3 interacts with HSP20. (A) Purified HSPB2 (0.5 µg) and 
HSPB2/B3 (1 µg) were incubated alone (lanes 3-4) or with a mixture of HSP20, HSP27 and αB-
crystallin (each 5 µg) (lanes 5-6) for 60 min at room temperature and subsequently 
immunoprecipitated (IP) using antibodies directed to HSPB2. As a negative control no proteins were 
added (lane 2). The precipitated proteins were analyzed by Western blotting using antibodies directed 
to the indicated proteins. Lane 1 shows 5% of the input of HSP20, HSP27 and αB-crystallin. (B) 
Purified HSPB2 (0.5 µg) and HSPB2/B3 (1 µg) were incubated with 5 µg HSP20 (upper panel), 5 µg 
HSP27 (middle panel) or 5 µg αB-crystallin (lower panel) (lanes 3-4) or with a mixture of the three 
proteins (each 5 µg) (lanes 5-6) for 60 min at room temperature and subsequently immunoprecipitated 
(IP) using the indicated antibodies. As a negative control HSPB2/B3 was incubated with buffer alone 
(lane 2). The precipitated proteins were analyzed by Western blotting with anti-HSPB2 serum. Lane 1 
shows 5% of the HSPB2/B3 input. 
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Table 1. Molecular masses of the detected HSPB2/B3 oligomers as determined by nano-ESI-MS, 
MALLS and sedimentation analysis and compared with the calculated masses. 
 
Multimers Nano-ESI-MS MALLS Sedimentation velocity analysis (AUC) 













n+4- and n-mer 
4-mer 77,673 77,897 ± 34 78,000 4.6 73,400 60.4 - 
8-mer 155,346 155,696 ±53 166,000 6.9 135,000 25.4 0,4 
12-mer 233,019 233,767 ± 94 - 8.8 197,000 7.9 0,3 
16-mer 310,692 311,853 ± 19 - 11.1 277,000 3.1 0,4 
20-mer 388,365 ND - 13.6 376,000 0.9 0,3 
24-mer 466,038 467,588 ±127 - 16.0 481,000 1.3 1,4 
    19.4 638,000 0.6 - 
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